These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37400950)
1. The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis. Rajendran R; Rajendran V; Böttiger G; Stadelmann C; Shirvanchi K; von Au L; Bhushan S; Wallendszus N; Schunin D; Westbrock V; Liebisch G; Ergün S; Karnati S; Berghoff M Br J Pharmacol; 2023 Dec; 180(23):2989-3007. PubMed ID: 37400950 [TBL] [Abstract][Full Text] [Related]
2. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M Cells; 2021 Apr; 10(4):. PubMed ID: 33924474 [TBL] [Abstract][Full Text] [Related]
3. Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase. Hao W; Luo Q; Menger MD; Fassbender K; Liu Y Front Immunol; 2021; 12():792465. PubMed ID: 34975892 [TBL] [Abstract][Full Text] [Related]
4. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980 [TBL] [Abstract][Full Text] [Related]
7. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis. Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242 [TBL] [Abstract][Full Text] [Related]
8. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms Involved in the Remyelinating Effect of Sildenafil. Díaz-Lucena D; Gutierrez-Mecinas M; Moreno B; Martínez-Sánchez JL; Pifarré P; García A J Neuroimmune Pharmacol; 2018 Mar; 13(1):6-23. PubMed ID: 28776122 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brambilla R; Ashbaugh JJ; Magliozzi R; Dellarole A; Karmally S; Szymkowski DE; Bethea JR Brain; 2011 Sep; 134(Pt 9):2736-54. PubMed ID: 21908877 [TBL] [Abstract][Full Text] [Related]
11. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling. Zhang D; Qiao L; Fu T Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388 [TBL] [Abstract][Full Text] [Related]
12. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice. Zeinali H; Baluchnejadmojarad T; Roghani M Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463 [TBL] [Abstract][Full Text] [Related]
13. Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation. Rajendran R; Giraldo-Velásquez M; Stadelmann C; Berghoff M Brain Pathol; 2018 Mar; 28(2):212-224. PubMed ID: 28117910 [TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-Specific Deletion of Rajendran R; Rajendran V; Giraldo-Velasquez M; Megalofonou FF; Gurski F; Stadelmann C; Karnati S; Berghoff M Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502405 [TBL] [Abstract][Full Text] [Related]
15. Potential of Adult Endogenous Neural Stem/Progenitor Cells in the Spinal Cord to Contribute to Remyelination in Experimental Autoimmune Encephalomyelitis. Maeda Y; Nakagomi N; Nakano-Doi A; Ishikawa H; Tatsumi Y; Bando Y; Yoshikawa H; Matsuyama T; Gomi F; Nakagomi T Cells; 2019 Sep; 8(9):. PubMed ID: 31484369 [TBL] [Abstract][Full Text] [Related]
16. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation. Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550 [TBL] [Abstract][Full Text] [Related]
17. Multiple Sclerosis CD49d Piatek P; Namiecinska M; Domowicz M; Wieczorek M; Michlewska S; Matysiak M; Lewkowicz N; Tarkowski M; Lewkowicz P Cells; 2019 Dec; 9(1):. PubMed ID: 31861635 [TBL] [Abstract][Full Text] [Related]
18. Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis. Gilgun-Sherki Y; Panet H; Melamed E; Offen D Brain Res; 2003 Nov; 989(2):196-204. PubMed ID: 14556941 [TBL] [Abstract][Full Text] [Related]
19. Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination. Pennati A; Nylen EA; Duncan ID; Galipeau J J Neurosci; 2020 Jun; 40(26):5105-5115. PubMed ID: 32430295 [TBL] [Abstract][Full Text] [Related]
20. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis. Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]